INTERNATIONAL PATENT: OBSIDIAN THERAPEUTICS, INC. FILES APPLICATION FOR "LOW DOSE LYMPHODEPLETION WITH ADOPTIVE CELL THERAPY"

GENEVA, May 12 -- OBSIDIAN THERAPEUTICS, INC. (1030 Massachusetts Ave.Fourth FloorCambridge, Massachusetts 02138) filed a patent application (PCT/US2025/053396) for "LOW DOSE LYMPHODEPLETION WITH ADOPTIVE CELL THERAPY" on Oct 30, 2025. With publication no. WO/2026/096805, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HARI, Parameswaran (c/o Obsidian Therapeutics, Inc.1030 Massachusetts Ave., Fourth FloorCambridge, Massachusetts 02138), JAGASIA, Madan (c/o Obsidian Therapeutics, Inc.1030 Massachusetts Ave., Fourth FloorC...